Manufactured by:ProteoGenix
Save 20%RUO

Recombinant Mouse Ifna15 Protein, N-His

Recombinant Mouse Ifna15 Protein, N-His from ProteoGenix; catalogue ARO-P10534; research use only.

SKU:
ABM140973-1
Manufacturer SKU
ARO-P10534
Product type
Recombinant Proteins
Expression systemProkaryotic expression

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

Introduction

Recombinant Mouse Ifna15 Protein, also known as Interferon alpha-15, is a type I interferon protein that plays a crucial role in the innate immune response against viral infections. This protein is produced through recombinant DNA technology, allowing for large-scale production and purification for various research and therapeutic applications. In this article, we will explore the structure, activity, and applications of Recombinant Mouse Ifna15 Protein.

Structure of Recombinant Mouse Ifna15 Protein

Recombinant Mouse Ifna15 Protein is a 20 kDa protein consisting of 166 amino acids. It belongs to the type I interferon family and shares a high degree of sequence homology with other interferon alpha proteins. The primary structure of Ifna15 protein contains a signal peptide at the N-terminus, followed by a conserved cysteine-rich domain and a highly variable C-terminal region. The cysteine residues in the conserved domain are important for the formation of disulfide bonds, which contribute to the stability and activity of the protein.

The three-dimensional structure of Recombinant Mouse Ifna15 Protein has been determined through X-ray crystallography. It adopts a compact globular conformation, with the conserved cysteine-rich domain forming a four-helix bundle and the C-terminal region extending outwards. This structure is similar to other type I interferons and is essential for its biological activity.

Activity of Recombinant Mouse Ifna15 Protein

Recombinant Mouse Ifna15 Protein exerts its activity through binding to the interferon alpha receptor (IFNAR), a heterodimeric receptor complex consisting of IFNAR1 and IFNAR2 subunits. Upon binding, the receptor activates the Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathway, leading to the transcription of interferon-stimulated genes (ISGs).

The main function of Recombinant Mouse Ifna15 Protein is to induce an antiviral state in cells, making them resistant to viral infection. It also has immunomodulatory effects, such as enhancing the activity of natural killer cells and promoting the differentiation of T cells. Additionally, Ifna15 protein has been shown to have anti-proliferative and pro-apoptotic effects on certain cancer cells, making it a potential candidate for cancer therapy.

Applications of Recombinant Mouse Ifna15 Protein

Recombinant Mouse Ifna15 Protein has a wide range of applications in both research and therapeutic settings. In research, it is commonly used as a positive control in experiments studying the interferon signaling pathway and its effects on immune cells. It is also used to induce an antiviral state in cells for the study of viral infections.

Therapeutically, Recombinant Mouse Ifna15 Protein has been investigated as a potential treatment for viral infections, such as hepatitis B and C, and various types of cancer. It has also been studied for its potential in treating autoimmune diseases, such as multiple sclerosis and lupus. Clinical trials have shown promising results, with some patients showing improved outcomes after treatment with Recombinant Mouse Ifna15 Protein.

Conclusion

In summary, Recombinant Mouse Ifna15 Protein is a type I interferon with a conserved structure and important biological activity. Its ability to induce an antiviral state and modulate the immune response makes it a valuable tool in research and a potential therapeutic agent for various diseases. Continued research on this protein will further enhance our understanding of its structure and activity, leading to the development of novel treatments for a range of conditions.

ProteoGenix catalogue number ARO-P10534. For research use only.

Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 21.62 kDa; Fragment: Cys24-Glu190; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Key facts & specifications
Also known as
Alpha-interferon, Interferon 1ai1, Interferon alpha 15, Predicted gene, OTTMUSG00000007655, Ifna15, Gm12597, If1ai1, MuIFN-alpha-A
Host species
E. coli
Source organism
Mouse
Molecular weight
21.62 kDa
Sequence fragment
Cys24-Glu190
Sequence
CDLPQTHNLRNKRALTLLVQMRRLSPLSCLKDRKDFRFPQEKVDAQQIQNAQAIPVLQELTQQVLNIFTSKDSSAAWDASLLDSFCNDLHQQLNDLKACVMQEVGVQEPPLTQEDYLLAVRTYFHRITVYLREKKHSPCAWEVVRAEVWRAMSSSAKLLARLSEEKE
Technical note
For research use only.
Identifiers & database references
Manufacturer SKU
ARO-P10534
UniProt accession
Q61718
Storage, stability & shipping
Storage conditions
4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
Shipped at
Dry Ice
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
$246.00$197.00